Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while ...

BofA analyst Michael Ryskin raised the firm’s price target on Idexx Laboratories (IDXX) to $535 from $475 and keeps a Neutral rating on the ...

We argue against selling Geron at current prices, citing strong market potential of imetelstat and Royalty Pharma deal ...

Teradyne's strategic expansion into power semiconductor testing through Infineon partnership positions it well for future EV growth. See why TER stock is a Buy.

Nvidia shares fell Monday after the Trump administration said it would impose tariffs, adding to steep losses for the stock that were fueled by concerns related to the success of Chinese startup ...

In the last three years, the government has virtually shut down the disinvestment and privatisation programme.

Market experts have shares their view on following stocks: LIC, IREDA, NTPC Green Energy, Bajaj Finserv, Reliance Industries, ...

The company has a predicted growth of -100.00% for revenue & -100.00% in profit for the quarter . IREDA Share Price Live Updates: Today, IREDA's share price increased by 0.27%, reaching ₹187.40, while ...

"I believe we may see some more downside in Nifty towards 22,500-21,700 levels. Trailing stop loss on the upside will be ...

Rupee strengthens against US dollar due to weak crude oil prices, positive domestic markets, and upcoming Union Budget impact.

IREDA Share Price Live Updates: The share price of IREDA decreased by 1.72% today, reaching ₹196.85, while its competitors are showing mixed performance. While JSW Infrastructure is experiencing a ...

Can history repeat in the Union Budget? Two railway PSU stocks, IRCTC and IRCON, are showing strong technical setups and could be poised for a rebound.